Aurobindo Pharma Limited — Important, 28-05-2025: General Updates

Aurobindo Pharma has announced a board meeting on the financial results for the quarter and half-year. Its subsidiary Curateq Biologics has set up a new wholly owned subsidiary in the Netherlands, CuraTeQ Biologics B.V., with an initial capital of EUR 10,000. This strategic move enhances Aurobindo’s footprint in the European biopharma market, supporting growth in its biologics segment.